XpresSpa Announces Third Quarter 2019 Financial Results on November 14, 2019
NEW YORK, Nov. 11, 2019 (GLOBE NEWSWIRE) — XpresSpa Group Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”), today announced that […]
Nemaura Medical Reports Results and Provides Business Update for the Second Quarter Ended September 30, 2019
Loughborough, England, Nov. 11, 2019 (GLOBE NEWSWIRE) — – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused […]
OrthoPediatrics Corp. to Present at Two Upcoming Investor Conferences
WARSAW, Ind., Nov. 11, 2019 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), an orthopedic company focused exclusively on advancing the […]
Hudson Technologies to Host Conference Call to Discuss Third Quarter 2019 Results
PEARL RIVER, N.Y., Nov. 11, 2019 (GLOBE NEWSWIRE) — Hudson Technologies, Inc. (NASDAQ: HDSN) will host a conference call and […]
Nutritional High Appoints Tom Kruesopon to Board of Directors
TORONTO, Nov. 11, 2019 (GLOBE NEWSWIRE) — Nutritional High International Inc. (“Nutritional High” or the “Company“) (CSE: EAT, OTCQB: SPLIF) […]
Green Plains Appoints Phil Boggs as Senior VP, Investor Relations and Treasurer, Jim Stark to become VP, Investor Relations at Darling Ingredients
OMAHA, Neb., Nov. 11, 2019 (GLOBE NEWSWIRE) — Green Plains Inc. (NASDAQ:GPRE) today announced that Phil Boggs, Senior Vice President, […]
iMedia Brands Sets Third Quarter 2019 Conference Call for Wednesday, November 20, 2019, at 8:30 a.m. ET
MINNEAPOLIS, Nov. 11, 2019 (GLOBE NEWSWIRE) — iMedia Brands, Inc. (NASDAQ: IMBI) will hold a conference call on Wednesday, November […]
Allogene Therapeutics Announces Year-End 2019 Media Event and Investor Conference Schedule
SOUTH SAN FRANCISCO, Calif., Nov. 11, 2019 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering […]
Turning Point Therapeutics Initiates Phase 1/2 Clinical Study of TPX-0046, a Novel RET/SRC Inhibitor
SAN DIEGO, Nov. 11, 2019 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing novel […]
FTE Networks Reports Extension of Indebtedness and Continuing Negotiations for Possible Business Combination
NEW YORK, Nov. 11, 2019 (GLOBE NEWSWIRE) — FTE Networks, Inc. (NYSE American: FTNW) (“FTE” or the “Company”) today announced […]
